Trial Details

COMPLETED
Basic Information
Clinical ID c3495
Identifier NCT01958827
Trial Title A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn's Disease
Interventions BIOLOGICAL: Adalimumab
Participant Information
Sponsor AbbVie
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2013-09
Primary Completion Date 2015-03
Completion Date 2015-10